Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al by Mondher Toumi, Samuel Aballea

Get full text

Measuring health-related quality of life in young children: how far have we come? by Nicola Germain, Samuel Aballéa, Mondher Toumi

Get full text

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe by Katarzyna Jabłońska, Samuel Aballéa, Pascal Auquier, Mondher Toumi

Get full text

Clinical Trial Validity Guidance from the HTACG: Looking for Chicken Teeth by Mondher Toumi, Bruno Falissard, Asma Jouini, Samuel Aballéa, Laurent Boyer

Get full text

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results by Junwen Zhou, Aurélie Millier, Clément François, Samuel Aballéa, Mondher Toumi

Get full text

Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer, Philippe Laramée

Get full text

Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach by Ru Han, Shuyao Liang, Clément François, Samuel Aballea, Emilie Clay, Mondher Toumi

Get full text

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK by Zalmai Hakimi, Con Kelleher, Samuel Aballéa, Khaled Maman, Jameel Nazir, Colette Mankowski, Isaac Odeyemi

Get full text

Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment by Mondher Toumi, Anastasiia Motrunich, Aurélie Millier, Cécile Rémuzat, Christos Chouaid, Bruno Falissard, Samuel Aballéa

Get full text

An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models by Michał Pochopień, Ewelina Paterak, Emilie Clay, Justyna Janik, Samuel Aballea, Małgorzata Biernikiewicz, Mondher Toumi

Get full text

Elicitation of Health-related Quality-of-life Concepts Associated with Overactive Bladder: A Qualitative Study by Natalia Hawken, Zalmai Hakimi, Samuel Aballéa, Jameel Nazir, Isaac A. O. Odeyemi, Mondher Toumi

Get full text

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease by Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov

Get full text

Impact of TAK-003 on epidemiologic, economic and quality-of-life burden of dengue: comparison of the results from a dynamic transmission model and a static model with a dynamic com... by Elizaveta Kharitonova, Dr Jing Shen, Anna Tytula, Justyna Zawieja, Yaneth Gil Rojas, Samuel Aballea, Riona Hanley

Get full text

Validating the Predictions of a Dynamic Transmission Model Using Real-World Data from a Universal Varicella Vaccination Program in Germany by Iwona Żerda, Tomasz Stanisz, Tomasz Fundament, Filip Chełmikowski, Wioletta Kłębczyk, Michał Pochopień, Emilie Clay, Samuel Aballéa, Mondher Toumi

Get full text

Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand by Jing Shen, Elizaveta Kharitonova, Anna Tytula, Justyna Zawieja, Samuel Aballea, Shibadas Biswal, Mayuri Sharma, Supattra Rungmaitree, Rosarin Sruamsiri, Derek Wallace, Riona Hanley

Get full text

Health economic evaluation of gene replacement therapies: methodological issues and recommendations by Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Postma, Mondher Toumi

Get full text